TechnoPhage is currently working on several projects in different therapeutic areas, such as infection, ophthalmology, or neuroscience, among which numerous patents have been placed throughout the years.

Did you know that the total number of ‘live’ patents in TechnoPhage’s portfolio is currently 166 patents in 25 jurisdictions all over the world?

A strong portfolio of patents allows TechnoPhage to remain competitive among its peers, this being a differentiating asset in a highly competitive area in which the company operates.